Aim While the expressed extracellular domains of the HLA antigens are responsible for determining antigenicity, there are nucleotide polymorphisms outside of this region that affect expression levels. In particular, several of the common well defined (CWD) null mutations lie outside of those typically amplified exons in SSO products (exon 2 and 3 for Class1; exon2 for Class 2) and cause the loss of antigen expression. The LIFECODES Null Allele SSO kit was developed to detect A*24:09N, B*51:11N, C*04:09N, DRB4*01:03:01:02N and DRB5*01:08N. When running standard SSO based assays, reflex testing is required for resolution of these null alleles. However, there is currently no single product that can resolve all of these null alleles. Methods Primers were designed to amplify exon 4 for HLA-A & B, exon 7 for HLA-C, exon 3 for DRB5 and the intron 1 - exon 2 border for DRB4. Probes were developed that are specific for the null alleles along with the complementary probes that are specific for the non-null alleles. Amplification conditions and hybridization conditions are identical to those of the other LIFECODES SSO products. The Null kit contains two assays: Null Class 1 and Null Class 2, composed of two separate PCR master mixes and one common probe mix for hybridization. Results Using input DNA from different sources, such as UCLA reference samples and whole blood preserved either in EDTA or ACD, the Null Class 1 and Null Class 2 assays showed ⩾ 97% typing accuracy per locus in 139 and 137 genomic samples, respectively. Both assays were generated expected typings using DNA ranging from 25 to 400 ng. Reproducibility among three lots and three operators showed ⩾ 99% concordance per locus for 162 Null Class 1 assays and for 126 Null Class 2 assays. Conclusions In a single product, the LIFECODES Null Allele SSO kit provides a method to simultaneously detect multiple CWD null alleles that lie outside of exon 2 and 3 for Class I and exon 2 for Class II.
Read full abstract